DM-Pharma

Ninove ·KBO/BCE: BE 0760.881.856

Loading dossier…

Checked · Insight, alerts and connections for every Belgian company, from official sources.

NL FR EN

Product

Search companies Sectors Radar Live Compare Prospects Supplier check Feasibility

Data & registers

Insolvencies Curators Directors Director bans Protection orders Notaries News

Account

Watchlist Portfolio Alerts Pricing

Checked

About Methodology Knowledge base Sources FAQ Help API Badge

Legal

Privacy Terms Contact

Checked AI

Open a company dossier to ask Checked AI about it.

Answers from Checked AI. Not legal advice.

Metric	This company	Sector median	Position in the sector
Solvency	31.8%	20.3%	better than 61% of 6648 sector peers
Net result	€28k	€4k	better than 80% of 6629 sector peers
Equity	€77k	€16k	better than 81% of 6662 sector peers
Gross operating margin	€53k	€24k	better than 67% of 6608 sector peers
Staff costs	€0	€33k	higher than 5% of 3011 sector peers

Line item	Code	2024
Balance sheet, Assets
TOTAL ASSETS	20/58	€241k
Fixed assets	21/28	€180k
Tangible fixed assets	22/27	€180k
Current assets	29/58	€61k
Amounts receivable within one year	40/41	€58k
Cash & bank	54/58	€2k
Balance sheet, Equity & liabilities
TOTAL EQUITY & LIABILITIES	10/49	€241k
Equity	10/15	€77k
Contributions / capital	10/11	€3k
Reserves	13	€47k
Accumulated profits (losses)	14	€27k
Amounts payable	17/49	€164k
Amounts payable after one year	17	€118k
Amounts payable within one year	42/48	€45k
Trade debts payable within one year	44	€3k
Income statement
Gross operating margin	9900	€53k
Operating result	9901	€44k
Financial charges	65	€8k
Result before taxes	9903	€36k
Income taxes	67/77	€8k
Net result for the period	9904	€28k
Result to be appropriated	9905	€28k

Summary